Parallax Volatility Advisers, L.P. Amneal Pharmaceuticals, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $257,600 - $571,600	-40,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $474,799 - $593,600	-40,000 Reduced 50.0%	40,000 $567,000
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $523,600 - $859,599	40,000 Added 100.0%	80,000 $1.08 Million
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $656,000 - $970,800	40,000 New	40,000 $888,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.